Amazentis
PrivateLast Round
Grant
May 12, 2025
Total Funding Raised
$87.36M
Company Overview
Amazentis operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a Grant round in May 2025.
Amazentis is a biotechnology company that develops nutritional and skincare products to combat aging and improve quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Sports & Fitness, Fashion & Beauty, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amazentis Comparables
Compare Amazentis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MitoQ | 88% | |
| Elysium Health | 83% | |
| NOVOS | 80% |
For institutional investors. Book with your work email.
Amazentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 12, 2025 | ||||
| Series D | Jan 17, 2024 | ||||
| Series B | Sep 25, 2023 | ||||
| Strategic | Apr 2, 2019 | ||||
| Series C | Mar 21, 2018 |
For institutional investors. Book with your work email.
Amazentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlackFin Capital Partners | Series B |
| Climb Ventures | Series D |
| ND Capital | Series C |
| BOLD (Business Opportunities for L'Oréal Development) | Series D |
| MTech Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
Recognized as a Top 40 global team for innovative approaches.
- May 12, 2025
Secured $250K in grant funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- adopts_technologyOct 1, 2026
In Oct '26, Timeline uses Magellan AI to discover niche shows and build a podcast roster that consistently meets performance goals.
For institutional investors. Book with your work email.
Amazentis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Amazentis's valuation, stock price, and market status.
Is Amazentis a public or private company?
Amazentis is a private company.
What is the current stock price of Amazentis?
Amazentis is a private company, so its shares have no public market price. Caplight tracks Amazentis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Amazentis worth (valuation)?
Valuation information for Amazentis is not publicly available.
Can I buy Amazentis stock?
Amazentis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Amazentis's last funding round?
Amazentis's most recent funding round was Grant on May 12, 2025.
Who are the main investors in Amazentis?
Key investors in Amazentis include BlackFin Capital Partners, BOLD (Business Opportunities for L'Oréal Development).
Will Amazentis IPO soon?
No public IPO plans have been announced for Amazentis.
How can I track Amazentis secondary market activity?
Caplight tracks bids, offers, and trades in Amazentis's shares on secondary markets.